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ABSTRACT 
All reported series of fever of unknown origin were reviewed to 
determine the frequency of tuberculosis as the final diagnosis 
in this syndrome. Thirty-seven series from 1930 to 1995 were 
identified, comprising 3056 patients. Tuberculosis accounted for 
7.9% of all diagnoses. Although methods of diagnoses changed 
over the period reviewed, rates of tuberculosis were relatively 
stable. Of 1366 patients with specific information regarding site 
of tuberculosis, extrapulmonary tuberculosis accounted for 
4.8% of all cases and pulmonary tuberculosis 2.3%. Tubercu- 
losis continues to be the final diagnosis in a significant pro- 
portion of patients with fever of unknown origin. Consideration 
should be given to empirical antituberculous therapy in per- 
sons with fever of unknown origin and a thorough but unre- 
vealing workup. 
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Fever of unknown origin (FIJO) is a classic syndrome that 
has fascinated physicians since at least the 1930~.‘-~ In 
1961, Petersdorf and Beeson reported on 100 cases and 
standardized the definition of FUO for subsequent inves- 
tigators’O: at least 3 weeks of unexplained fever that has 
not been diagnosed despite extensive evaluation. Since 
then, at least 27 additional series with details of final diag- 
noses have been reported. Il.17 In most series, the vast 
majority of diagnoses are accounted for by one of the “Big 
Three”: infection, cancer, and collagen vascular disease.13 
Tuberculosis is the single most common infectious 
cause of FUO in many of these series. Although “classic” 
tuberculosis is often simple to diagnose, the difficulties 
in diagnosing tuberculosis in certain patients are legion. 
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Many physicians have experienced the humbling call 
from the microbiology laboratory notifying them that tis- 
sue samples of a patient, perhaps already discharged or 
deceased, are growing Mycobacterium tuberculosis in 
culture. This diagnostic difficulty appears heightened in 
patients infected with human immunodeficiency virus 
(HIV), since numerous other opportunistic infections may 
present with similar symptoms. 
To determine whether the rate of tuberculosis as a 
cause of FUO has changed over time, varies by country, 
or differs according to host population, all reported series 
of FUO were reviewed.The wisdom of giving a trial of 
empirical antituberculous therapy to such patients in 
light of these results is considered. 
METHODS 
Using MEDLINE, the English language literature since 
1966 was searched for “fever of unknown origin.” Addi- 
tional reports were identified by reviewing the bibli- 
ographies of these articles. Reports that did not include 
specific numbers of patients or specific diagnoses were 
excluded. 
RESULTS 
Thirty-seven studies with specific information regarding 
final diagnoses were identified, including reports from 
North and South America, Asia, Africa, and Europe. Nine 
reports predated the Petersdorf and Beeson series (Table 
1) including the article by Alt and Barker.’ Twenty reports 
in adults that adhered to the Petersdorf and Beeson def- 
inition of FUO were identified (Table 2) and eight series 
reported outcome in specific hosts, including those with 
HIV infection, the elderly, and the young (Table 3). 
The 37 series comprised 3056 patients.Two often- 
cited series,13J8 accounting for 350 patients, did not give 
specific information about tuberculosis and are excluded 
from further analysis. In addition, three other studies did 
not give sufficient information about etiologies other than 
tuberculosis and are considered only when cases of tuber- 
culosis are analyzed. 12~20~2s Of the 2509 patients with 
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Table 1. Studies Reported Prior to Petersdorf-Beeson Definition of FUO (n = 9) 
Author 
Fever Hospital 
Duration Location 
Study 
Period 
Alt & Barker’ >iOd Boston 1913-29 
Total 
Diagnosis % * Tuberculosist 
Cases Inf CA CVD Unk Number (%) Type - 
Kinter & Rowntree2 1 mo Mayo Clinic 1919-30 
KeefeP months Boston City 1931-39 
Hamman & WalnwrighV wk-mo* Johns Hopkins 1930s 
Hamman & Wainwright5 wk-mo§ Johns Hopkins 1930s 
Bottiger” >lOd Karolinska 1940-49 
Petterssot? >6 d Finland 1950-59 
Geraci et aI8 >2 wk Mayo Clinic1 ?-I 959 
Fransen & Bottigerg 2 wk Stockholm 1960 
57 16 11 0 63 5 (9) 2P 
100 35 N/A N/A 65 0 (0) ;; ;; 
0 EP 
80 64 21 0 0 8UO) OP 
8 EP 
36 19 6 0 75 2 16) 2P 
54 59 22 0 19 9 ii 7) 
0 EP 
N/A P 
I  ,  
N/A EP 
6% 16 10 4 69 4 (6) IP 
3 EP 
83 18 6 6 67 9(ll) 7P 
2 EP 
70 21 30 1 20 5 (7) OP 
5 EP 
60 12 32 7 45 5 (8) 1P 
4 EP 
*Does not include patients with “Other” diagnoses (e.g., drug fever, factitious fever, pulmonary embolus, etc.); tincluded in “Infection” diagnosis group (P = pulmonary; 
EP = extrapulmonary); *low-grade fever; shigh-grade fever: Iall patients underwent laparoscopy. 
Inf = infection; CA = cancer; CVD = collagen vascular disease, Unk = unknown: N/A = not available. 
complete information, infection was the diagnosis in 37%, 
cancer in 15%, and collagen vascular disease in lO%.These 
rates approximate those reported by Jacoby and Swartz 
(see Table 2). l3 
Tuberculosis was a diagnosis in at least one patient 
in 32 of the 35 series. Of the three series in which tuber- 
culosis was not a diagnosis, one was a study from the 
1930~.~ In this article, Kinter and Rowntree make an 
impassioned point that tuberculosis is too often the mis- 
taken diagnosis in patients with FUO.The other two series 
were relatively small (22 and 25 patients).2zs30 
In all, tuberculosis accounted for 214 (7.9%) of 
the diagnoses in the 2706 patients with adequate 
information (median 8%, range O-42%). The rate 
was stable for the nine studies performed before 
the Petersdorf and Beeson article (7.7%) (see Table 
1) and in the 20 adult series since (8.2%) (see Table 
2). Among series conforming to the Petersdorf-Bee- 
son definition, tuberculosis was more common in 
the non-US series (10.2%) than in the US series 
(5.3%) (see Table 2). Among specific populations, 
tuberculosis was responsible for FUO in 16.7% of 
patients with acquired immunodeficiency syn- 
drome (AIDS), 9.5% of elderly patients, and 2.9% 
of pediatric patients (see Table 3). In four series 
from community hospitals, the rate was 5.9%, 
including 3.5% of cases reported from American 
community hospitals (see Table 2).22,23a27,29 
In series involving 1366 patients, information con- 
cerning site of tuberculosis was available. Of these, 98 (7.2%) 
were diagnosed with tuberculosis, including extrapul- 
monary tuberculosis in 66 patients (4.8%) and pulmonary 
tuberculosis in 32 (2.3%).All cases of tuberculosis in the 
series focusing on the elderly were extrapulmonary33~34 
DISCUSSION 
Fever of unknown origin is a classic syndrome long 
beloved by teachers and students, for the differential diag- 
nosis is vast and traverses all of internal medicine. Mas- 
tering the approach to diagnosis remains a challenge in 
an ever-changing world of radiologic, serologic, and micro- 
biologic advancesThe syndrome of FUO has spawned at 
least the 37 studies included here, numerous additional 
reviews,38-40 and a handful of less memorable other 
acronyms: PLJO (pyrexia of unknown origin) was sug- 
gested by early authors3 but not surprisingly, rapidly fell 
into disuse. Similarly, the equally problematic FOO (fever 
of obscure origin) briefly held sway,6-8,11 but finally 
yielded to the now ubiquitous FUO, which may refer to 
fevers of unexplained, lo undetermined, l3 unknown, l6 or 
uncertain32 origin. 
As this review demonstrates, tuberculosis continues 
to be the cause of FUO in a significant number of 
patients, regardless of decade of study, continent, type of 
hospital, or underlying disease. Not surprisingly, extra- 
pulmonary tuberculosis accounted for twice as many 
cases as pulmonary tuberculosis (about 5% of all cases), 
again emphasizing how exasperatingly difficult it may be 
to establish the diagnosis of extrapulmonary tuberculo- 
sis in certain patients. Rates were higher among AIDS 
patients, the elderly, in series reported from referral hos- 
pitals, and in non-US series. 
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Table 2. Reported Studies Utilizing the Petersdorf-Beeson Definition (n = 20) 
Author 
Study 
Location Period 
Total 
Cases Inf 
Diagnosis %* 
CA CVD Unk 
Tuberculosis* 
Number (%) Type 
Petersdorf & Beeson’O New Haven 1952-57 100 36 19 15 
Sheon & Van Ommen” Cleveland 1959-60 60 22 17 13 
Lascurain & Perez-Padillai2 Mexico City 1951-70 65 N/A N/A N/A 
Jacoby & Swartz33 Boston 1957-71 128* 40 20 15 
DealI Gainesville 1960s 34 35 21 15 
Eyckmans et ali5 Leuven, BLG 1965-72 80 34 19 9 
Barbado et ali6 Madrid 1968-81 134 31 18 13 
Howard et all7 Temple, TX 1969-71 100 37 31 19 
Aduan et ali8 NIH 16~ 222 8 11 15 
Larson et alI9 Seattle 1970-80 105 30 31 9 
Arriaga et alZo Mexico City 1971-77 55 N/A N/A N/A 
Hassan & FaridZ1 Cairo 1971-73 129 60 14 10 
Fiala et alZ2 Los Angeles” 1976-77 22 64 18 0 
Gleckman et alZ3 Boston5 1970s 34 21 9 9 
SmithZ4 Dallas VAH 1979-85 80 50 15 1 
Lotholary et alZ5 Paris 1980-88 103 35 20 19 
Knockaert et aIns Leuven, BLG 1980-89 199 23 7 21 
Kazanjiar? Rhode Island” 1984-90 86 33 24 16 
Ponce-de-Leon-Rosales et alZ8 Mexico City 1988-93 77 N/A N/A N/A 
Shoji et alz9 Shin’etsu, Jpn§ 1986-92 80 54 9 16 
7 11 (11) 
38 3 (5) 
N/A 8 (12) 
5-8 N/A 
21 4 (12) 
13 7 (9) 
21 15 (11) 
5 3 (3) 
29 N/A 
12 4 (4) 
N/A 8 (15) 
12 21 (16) 
0 0 0 
35 2 (6) 
9 3 (4) 
17 11 (11) 
26 10 (5) 
9 3 (3) 
N/A 6 03) 
18 8 (10) 
4P 
7 EP 
2P 
1 EP 
N/A 
N/A 
N/A 
N/A 
2P 
2 EP 
N/A 
N/A 
N/A 
N/A 
OP 
3 EP 
N/A 
N/A 
OP 
4 EP 
N/A 
N/A 
N/A 
N/A 
OP 
0 EP 
OP 
2 EP 
N/A 
N/A 
5P 
6 EP 
N/A 
N/A 
IP 
2 EP 
N/A 
N/A 
5P 
3 EP 
*Does not include patients with “Other” diagnoses (e.g., drug fever, factitious fever, pulmonary embolus, etc.); iincluded in “Infection” diagnosis group (P = pulmonary; 
EP = extrapulmonary); *percentages apparently include both 128 cases seen by authors and a literature review; “community hospital-based study, 
Inf = infection; CA = cancer; CVD = collagen vascular disease, Unk = unknown: N/A = not available. 
Many reports on FUO through the years have made 
the nostalgic point that FUO was somehow “not what it 
used to be.“Z4 The current review suggests otherwise: cer- 
tainly, improved diagnostic techniques and the ready avail- 
ability of more serologic tests and radiologic studies have 
had a major impact in what finally is diagnosed, as noted 
by Larson et al. l9 However, among the 19 series in adults 
that utilized a standard definition, infection accounted 
for 37% of diagnoses, cancer 15%, and collagen vascular 
disease lo%, rates similar to those reported in 1973.13 
Thus, although specific types of cancer and infection may 
differ in recent series versus those from the 1950s the 
overall rates of the Big Three are the same: infection is 
about twice as common as cancer.This is important to 
consider when coordinating the workup of the patient 
with FUO. Interestingly, the spectrum of etiologies caus- 
ing FUO in the horse is similar to that seen in man.*l In 
one series of 63 cases of equine FUO, 43% were caused 
by infections (including 1 case of tuberculosis), 22% by 
neoplastic diseases, and at least 6% by “immune-mediated 
diseases.” 
The topic of fever and FUO has been addressed by 
many giants in the field of infectious disease, including 
Petersdorf, Beeson,Wolff, and Weinstein. In 1956, another 
of these giants, Ivan Bennett, noted “there is little to be 
gained by reviewing typical ‘textbook’ descriptions of 
diseases producing fever” since common diseases pre- 
senting uncommonly accounted for the majority of diag- 
noses.42 The persistence of M. tuberculosis as the cause 
of FUO through the decades and across the continents 
certainly confirms this notion. For, after all of these years, 
through countless “revolutions” in diagnostic technique, 
ranging from fine-needle aspiration, radiometric culture 
techniques, computer-based radiologic scans, tubercu- 
lostearic acid assays, and most recently, molecular analy- 
sis by genetic probe or polymerase chain reaction, 
tuberculosis has continued to bedevil the physician con- 
fronted with a patient who has persistent fever. Based 
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Table 3. Series Reported in Specific Populations (n = 8) 
Author 
Study Hospital Study Total 
Diagnosis % * Tuberculosist 
Population Location Period Cases Inf CA CVD Unk Number (%) Type 
Sepkowitz et aIs0 AIDS New York 1988-90 25 60 16 0 16 0 (0) OP 
0 EP 
Bissuel et aI31 AIDS Paris 1989-91 57 72 7 0 14 10 (18) N/A 
N/A 
Miralles et aIs* AIDS Madrid 1991-92 50 82 4 0 12 21 (42) N/A 
N/A 
Esposito & GleckmarF Elderly Literature* 1961-78 111 37 23 25 5 9 (8) OP 
9 EP 
Knockaert et al34 Elderly5 Leuven, BLG 1980-89 47 25 13 32 13 6 0 3) OP 
6 EP 
McClung35 Pediatric Wisconsin 1959-69 99 29 8 11 21 2 (2) OP 
2 EP 
Pizza et alss Pediatric Boston 1966-72 100 52 6 20 12 1 (1) N/A 
N/A 
Chantada et aF Pediatric Argentina 1987-91 113 36 10 13 19 6 (5) N/A 
N/A 
*Does not include patients with “Other” diagnoses (e.g., drug fever, factitious fever, pulmonary embolus, etc.): iincluded in “Infection” diagnosis group (P = pulmonary: 
EP = extrapulmonary); *literature review: rincluded in 199 patients reported by Knockaeti et a/.26 
Inf = infection; CA = cancer; CVD = collagen vascular disease; Unk = unknown; N/A = not available, 
on this review, institution of a trial of empirical anti- 
tuberculous therapy in any patient with FUO and no evi- 
dent diagnosis after the first set of diagnostic procedures 
deserves strong consideration. 
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